162 related articles for article (PubMed ID: 31940762)
1. Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics.
Li CC; Hsieh MJ; Wang SS; Hung SC; Lin CY; Kuo CW; Yang SF; Chou YE
Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31940762
[TBL] [Abstract][Full Text] [Related]
2. Impact of matrix metalloproteinase-11 gene polymorphisms on development and clinicopathologcial variables of uterine cervical cancer in Taiwanese women.
Ng SC; Wang PH; Lee YC; Lee CY; Yang SF; Shen HP; Hsiao YH
Int J Med Sci; 2019; 16(6):774-782. PubMed ID: 31337950
[TBL] [Abstract][Full Text] [Related]
3. WISP1 genetic variants as predictors of tumor development with urothelial cell carcinoma.
Lee HL; Chiou HL; Wang SS; Hung SC; Chou MC; Yang SF; Hsieh MJ; Chou YE
Urol Oncol; 2018 Apr; 36(4):160.e15-160.e21. PubMed ID: 29277583
[TBL] [Abstract][Full Text] [Related]
4. Effects of Long Noncoding RNA H19 Polymorphisms on Urothelial Cell Carcinoma Development.
Yang PJ; Hsieh MJ; Hung TW; Wang SS; Chen SC; Lee MC; Yang SF; Chou YE
Int J Environ Res Public Health; 2019 Apr; 16(8):. PubMed ID: 31013794
[TBL] [Abstract][Full Text] [Related]
5. Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma.
Wang B; Hsu CJ; Lee HL; Chou CH; Su CM; Yang SF; Tang CH
Int J Med Sci; 2018; 15(6):653-658. PubMed ID: 29725257
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Matrix Metalloproteinase-11 Polymorphisms on Colorectal Cancer Progression and Clinicopathological Characteristics.
Huang HC; Shiu BH; Su SC; Huang CC; Ting WC; Chang LC; Yang SF; Chou YE
Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885589
[TBL] [Abstract][Full Text] [Related]
7. Impact of endothelial nitric oxide synthase polymorphisms on urothelial cell carcinoma development.
Tsay MD; Hsieh MJ; Wang SS; Wang WC; Chou YY; Shih CH; Yang SF; Chou YE
Urol Oncol; 2019 Apr; 37(4):293.e1-293.e9. PubMed ID: 30611644
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor D2 genetic variations is associated with the risk and clinicopathological variables of urothelial cell carcinoma in a Taiwanese population.
Tung MC; Wen YC; Wang SS; Lin YW; Liu YC; Yang SF; Chien MH
Int J Med Sci; 2018; 15(11):1187-1193. PubMed ID: 30123056
[TBL] [Abstract][Full Text] [Related]
9. Impact of RAGE polymorphisms on urothelial cell carcinoma clinicopathologic characteristics and long-term survival.
Hung SC; Wang SS; Li JR; Chen CS; Lin CY; Chang LW; Chiu KY; Cheng CL; Ou YC; Yang SF
Urol Oncol; 2019 Sep; 37(9):573.e9-573.e17. PubMed ID: 30824390
[TBL] [Abstract][Full Text] [Related]
10. Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma.
Tsay MD; Hsieh MJ; Lee CY; Wang SS; Chen CS; Hung SC; Lin CY; Yang SF
Int J Environ Res Public Health; 2019 Dec; 17(1):. PubMed ID: 31878098
[TBL] [Abstract][Full Text] [Related]
11. Impact of EZH2 polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic features.
Yu YL; Su KJ; Hsieh MJ; Wang SS; Wang PH; Weng WC; Yang SF
PLoS One; 2014; 9(4):e93635. PubMed ID: 24691023
[TBL] [Abstract][Full Text] [Related]
12. Effect of
Hung SC; Wang SS; Li JR; Chen CS; Yang CK; Chiu KY; Cheng CL; Ou YC; Ho HC; Yang SF
Int J Med Sci; 2018; 15(14):1731-1736. PubMed ID: 30588197
[TBL] [Abstract][Full Text] [Related]
13. Impacts of CA9 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan.
Wang SS; Liu YF; Ou YC; Chen CS; Li JR; Yang SF
PLoS One; 2013; 8(12):e82804. PubMed ID: 24349364
[TBL] [Abstract][Full Text] [Related]
14. Associations of VEGF-C genetic polymorphisms with urothelial cell carcinoma susceptibility differ between smokers and non-smokers in Taiwan.
Tung MC; Hsieh MJ; Wang SS; Yang SF; Chen SS; Wang SW; Lee LM; Lee WJ; Chien MH
PLoS One; 2014; 9(3):e91147. PubMed ID: 24608123
[TBL] [Abstract][Full Text] [Related]
15. Genetic Variations of Melatonin Receptor Type 1A are Associated with the Clinicopathologic Development of Urothelial Cell Carcinoma.
Lin YW; Wang SS; Wen YC; Tung MC; Lee LM; Yang SF; Chien MH
Int J Med Sci; 2017; 14(11):1130-1135. PubMed ID: 29104467
[TBL] [Abstract][Full Text] [Related]
16. Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India.
Srivastava P; Kapoor R; Mittal RD
Urol Oncol; 2013 Feb; 31(2):247-54. PubMed ID: 21784671
[TBL] [Abstract][Full Text] [Related]
17. Impacts of ICAM-1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan.
Wang SS; Hsieh MJ; Ou YC; Chen CS; Li JR; Hsiao PC; Yang SF
Tumour Biol; 2014 Aug; 35(8):7483-90. PubMed ID: 24789429
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients.
Tan HZ; Wu ZY; Wu JY; Long L; Jiao JW; Peng YH; Xu YW; Li SS; Wang W; Zhang JJ; Li EM; Xu LY
BMC Cancer; 2016 Jul; 16():560. PubMed ID: 27472962
[TBL] [Abstract][Full Text] [Related]
19. Genetic instability persists in non-neoplastic urothelial cells from patients with a history of urothelial cell carcinoma.
de Castro Marcondes JP; de Oliveira ML; Gontijo AM; de Camargo JL; Salvadori DM
PLoS One; 2014; 9(1):e86162. PubMed ID: 24465937
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and predictive value of epigenetic biomarkers and clinical factors in upper tract urothelial carcinoma.
Xiong G; Liu J; Tang Q; Fan Y; Fang D; Yang K; Xie F; Zhang M; Zhang L; Liu L; Zhang C; Yao L; Yang L; Ci W; Zhao W; Gong Y; He Q; Gong K; He Z; Wang G; Li X; Guo Y; Zhou L
Epigenomics; 2015 Aug; 7(5):733-44. PubMed ID: 25912368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
